Back to Search
M CAREY ROACH, MD
MD
Internal Medicine Physician
NPI: 1922005974IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
E2521(AR)
Pediatrics Physician
Pediatrics
Code: 208000000X
E2521(AR)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Predictive models in external beam radiotherapy for clinically localized prostate cancer.
PMID 19544539·Cancer·2009
6-review
Microarray analysis of developing flax hypocotyls identifies novel transcripts correlated with specific stages of phloem fibre differentiation.
PMID 18593690·Ann Bot·2008
8-other
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610.
PMID 18172188·J Clin Oncol·2008
3-trial
Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both?
PMID 18167004·Strahlenther Onkol·2007
4-observational
Base metal alloys used for dental restorations and implants.
PMID 17586146·Dent Clin North Am·2007
6-review
Microarray analysis of flax (Linum usitatissimum L.) stems identifies transcripts enriched in fibre-bearing phloem tissues.
PMID 17503083·Mol Genet Genomics·2007
8-other
Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.
PMID 17498886·Int J Radiat Oncol Biol Phys·2007
3-trial
Goserelin acetate in combination with radiotherapy for prostate cancer.
PMID 17257094·Expert Opin Pharmacother·2007
6-review
Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score?
PMID 17167758·Cancer·2007
8-other
Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
PMID 17084158·J Urol·2006
8-other
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.
PMID 16798415·Int J Radiat Oncol Biol Phys·2006
8-other
Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer.
PMID 16256275·Cancer Treat Rev·2005
8-other
Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer.
PMID 15123413·Urol Clin North Am·2004
6-review
Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long?
PMID 14610408·J Urol·2003
6-review
Serum prostate-specific antigen and survival after external beam radiotherapy for carcinoma of the prostate.
PMID 12670556·Urology·2003
4-observational
Race and survival of men treated for prostate cancer on radiation therapy oncology group phase III randomized trials.
PMID 12478146·J Urol·2003
8-other
Methods for the isolation and maintenance of murine embryonic stem cells.
PMID 11768982·Methods Mol Biol·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11415 EXECUTIVE CENTER DR
LITTLE ROCK, AR 72211 - Phone
- (501) 224-5220
Quick Facts
- NPI
- 1922005974
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile